News

Iambic Therapeutics, Inc., an AI drug discovery company backed by Nvidia Corp. (NASDAQ:NVDA) and the Qatar Investment Authority, filed for an initial public offering, according to an S-1 filing with the SEC on Monday. Plans to List on Nasdaq, Under Ticker ‘IAM’ Iambic said it plans to use the IPO proceeds, along with its existing cash, to continue advancing its three cancer drug candidates through clinical development, with any remaining funds going toward general operating costs. It will go pub

A single quarter-point rate hike just wiped out hundreds of billions in NVIDIA's market value, and the forces behind that move are only getting more entangled with the AI buildout's financing structure.

It's easy to forget that this stock-picking outfit also outright owns a bunch of reliably profitable businesses.

Tech stock news for the week of Sept. 21.

Jim Cramer posted something about Oracle that tells investors more about the state of the AI trade.

Westinghouse's IPO could unlock significant value for its owners.

Nvidia and Micron headline a Q3 earnings season marked by broad-based growth, with both companies expected to deliver major year-over-year gains.

Nscale, a cloud computing rival of CoreWeave and Nebius, has filed for an IPO. Nscale stock will trade on the NYSE.

Trump’s Federal Open Market Committee (FOMC) scoldings continue to fall on deaf ears.

You need an actual strategy to avoid falling behind.

A growing Silicon Valley divide takes a more personal turn

The leading network airline is a very different business from what it was a decade ago, and it might be time for the market to rerate its stock.

Bond yields rose ahead of the Fed rate hike, and investors should be worried about Wall Street and Main Street.

The U.S. economy is strong, but a valuation problem looms over the stock market.

Amazon and Alphabet will benefit in two big ways from Anthropic's IPO.

The Federal Reserve just raised interest rates for the first time in more than three years.

Until Anthropic goes public, investors won't have any great options to get exposure to the performance of its shares.

Jim Cramer has plenty to say about stocks, but his latest comments on AMD took a notably different tone.

The Federal Open Market Committee (FOMC) just raised interest rates for the first time in three years.

The Anthropic IPO will be delayed until November, the WSJ reported. OpenAI forecast massive negative cash flow, the FT reported.

If you pay attention to history, the rate hike doesn't bode well for the markets.

Blockbuster IPOs rarely live up to the hype.

The market will be highly affected by this IPO, even if the stock isn't included in the index right away.

It's always a smart, disciplined holding. That doesn't mean it's always immune to sweeping headwinds.

The Federal Reserve has undertaken six previous rate-hiking cycles since 1990, with each yielding highly predictable results for the stock market.

The Nvidia chief makes the case for engineering solutions—not new laws or industry speed bumps—to address AI safety concerns.

SpaceX completed the largest IPO in history in June.

Despite Nvidia's growth, the return on such a modest investment may be surprising.

With Micron’s earnings report looming, competitors have weighed in on the same pressure they’re all feeling.

S&P 500 earnings in Q3 are expected to increase by +24% from the same period last year, reflecting the 8th consecutive quarter of double-digit earnings growth for the index. Earnings revisions have been positive, sustaining the favorable trend in place for almost a year now.